Wells Fargo Downgrades Enzymotec (ENZY) to Market Perform
Tweet
Share
E-mailGet Alerts ENZY Hot Sheet
Price: $11.85 --0%
Rating Summary:
2 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Rating Summary:
2 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Join SI Premium – FREE
Wells Fargo downgraded Enzymotec (NASDAQ: ENZY) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Enzymotec click here. For more ratings news on Enzymotec click here.
Shares of Enzymotec closed at $5.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
- Kepler Cheuvreux Downgrades Carl Zeiss Meditec AG (AFXG:GR) (CZMWY) to Reduce
Create E-mail Alert Related Categories
DowngradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
